RPS5 negatively regulates the expression of p53 and plays an anti-apoptotic role in cancer cells, conferring resistance to mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor-induced cell death [100]. This evidence concerns the gene MAP2K7 and cancer.